Skip to content

Diazyme DZ168C-CON

by Diazyme Laboratories, Inc.

Ref DZ168C-CON

Diazyme DZ168C-CON is an in vitro diagnostic device (EU IVDD general IVD; FDA Class I) made by Diazyme Laboratories, Inc., registered in EUDAMED on 27 Oct 2026 (Basic UDI-DI B-DZ168C-CONRE), cleared under FDA 510(k) K160762 on 21 Nov 2016 and listed in FDA GUDID since 21 Jul 2020 (UDI-DI D-DZ168C-CONRE), active as of 7 Nov 2026.

Active European Union and United States. Also listed in GUDID (US).

CE IVDD 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None found

in data synced 7 Nov 2026

Documents

None linked in EUDAMED

A group certificate may exist

510(k) K160762

FDA submission, from GUDID

Trust

Unverified

Source EUDAMED, GUDID, synced 7 Nov 2026.

Regulatory status

as of registry sync 7 Nov 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD EUDAMED NumberB-DZ168C-CONRE Basic UDI-DI D-DZ168C-CONREUDI-DIDate27 Oct 2026RegisteredStatusActive
United StatesGUDID listing GUDID NumberD-DZ168C-CONRE UDI-DI Date21 Jul 2020ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE GUDID from GUDID Substantially Equivalent · Traditional NumberK160762 Date21 Nov 2016DecidedStatusActive

Official records

From the FDA record

MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 7 Nov 2026, as the labeller entered it.

Across registries

3 registries list this device

  • EUDAMED Basic UDI-DI B-DZ168C-CONRE registered 27 Oct 2026 Active
  • FDA 510(k) K160762 decided 21 Nov 2016 Active
  • FDA GUDID UDI-DI D-DZ168C-CONRE listed 21 Jul 2020 Listed

Timeline

3 dated events

  1. Cleared FDA 510(k) K160762
  2. Listed FDA GUDID D-DZ168C-CONRE
  3. Registered EUDAMED B-DZ168C-CONRE

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDD Active
  • United States FDA 510(k) Active

Specification

EUDAMED · GUDID

Trade name
Diazyme Direct HbA1c Assay Control Set EUDAMED
Diazyme GUDID
Generic name
Glycated haemoglobin (HbA1c) IVD, control
Model / reference
DZ168C-CON
Primary DI / UDI-DI
D-DZ168C-CONRE EUDAMED
00817089021365 GUDID
Basic UDI-DI
B-DZ168C-CONRE
510(k) Number
FDA product code
JJX, LCP
EMDN code
W0101050205 Diabetes controls
GMDN term
Glycated haemoglobin (HbA1c) IVD, control
Device class
Class IVD General EUDAMED
Class I GUDID
Regulation number
862.1660, 864.7470
EU registration type
Legacy device (under a directive)
EU market of registration
Germany
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 2 fields differ

FieldEUDAMEDGUDID
Primary DI / UDI-DIEUDAMED
D-DZ168C-CONRE
GUDID
00817089021365
Device classEUDAMED
Class IVD General
GUDID
Class I

The registries describe this device under different primary UDI-DIs (EUDAMED lists D-DZ168C-CONRE; FDA GUDID lists 00817089021365), so their flags are not compared. Device class is stated on each registry's own scale: Class IVD General in the EU (EUDAMED), Class I in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under DIABETES CONTROLS.

Other devices from Diazyme Laboratories, Inc.

See all devices from Diazyme Laboratories, Inc. →

Properties

  • Contains human tissues or cells
  • Professional testing
  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (20, all answered No)